Pages that link to "Q73545672"

The following pages link to Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines (Q73545672):

Displaying 39 items.

• Mechanism of oral tolerance induction to therapeutic proteins (Q26866369) ‎ (← links)
• Oral tolerance: mechanisms and therapeutic applications. (Q33683196) ‎ (← links)
• Dominant regulation: a common mechanism of monoclonal antibody induced tolerance? (Q33723083) ‎ (← links)
• The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes (Q33947964) ‎ (← links)
• Immunotherapy of immune-mediated diabetes. Present and future (Q34118463) ‎ (← links)
• Mucosal immunity and vaccines (Q34409172) ‎ (← links)
• TGF-beta signaling is required for the function of insulin-reactive T regulatory cells (Q34576601) ‎ (← links)
• Prospects for the prevention and reversal of type 1 diabetes mellitus (Q35016963) ‎ (← links)
• Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein. (Q35101668) ‎ (← links)
• Gene- and cell-based therapeutics for type I diabetes mellitus (Q35122170) ‎ (← links)
• Vaccine therapies for the prevention of type 1 diabetes mellitus (Q35212181) ‎ (← links)
• Overview of prevention and intervention trials for type 1 diabetes (Q35583872) ‎ (← links)
• Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus (Q35583901) ‎ (← links)
• A targeted mutation in the IL-4Ralpha gene protects mice against autoimmune diabetes (Q35822833) ‎ (← links)
• Regulatory T-cells in type 1 diabetes (Q35896345) ‎ (← links)
• The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model (Q36017123) ‎ (← links)
• Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease (Q36172835) ‎ (← links)
• Expression of a ricin toxin B subunit: insulin fusion protein in edible plant tissues (Q36591189) ‎ (← links)
• Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity (Q36906352) ‎ (← links)
• Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. (Q41700461) ‎ (← links)
• Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm (Q42035404) ‎ (← links)
• Bystander suppression induced by oral tolerance (Q44021531) ‎ (← links)
• DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice. (Q45886074) ‎ (← links)
• Prevention of type 1 diabetes (Q47678735) ‎ (← links)
• Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group. (Q51554328) ‎ (← links)
• Diversification of response to hsp65 during the course of autoimmune arthritis is regulatory rather than pathogenic. (Q54119203) ‎ (← links)
• Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. (Q54544388) ‎ (← links)
• Infectious tolerance. (Q55068093) ‎ (← links)
• Immune Mechanisms and Pathways Targeted in Type 1 Diabetes (Q57166646) ‎ (← links)
• Dominant transplantation tolerance impairs CD8+ T cell function but not expansion (Q61651663) ‎ (← links)
• Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice (Q61658663) ‎ (← links)
• Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial (Q62587898) ‎ (← links)
• Cytokine profile and insulin antibody IgG subclasses in patients with recent onset Type 1 diabetes treated with oral insulin (Q63348373) ‎ (← links)
• Oral Vaccine Delivery for Intestinal Immunity-Biological Basis, Barriers, Delivery System, and M Cell Targeting. (Q64974251) ‎ (← links)
• Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes (Q73655322) ‎ (← links)
• Oral tolerance and the treatment of rheumatoid arthritis (Q77627766) ‎ (← links)
• Selective immunotherapy of IDDM: a discussion based on new findings from the RIP-LCMV model for autoimmune diabetes (Q77725121) ‎ (← links)
• Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants (Q81563828) ‎ (← links)
• Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism (Q84081029) ‎ (← links)